Fundraising FoxSchmidt — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Pinetreetxpinetreetx.comJul 2024
Pine Tree Therapeutics develops therapies based on targeted protein degradation, with a focus on addressing drug resistance.
BiotechCambridge, US
Ho-Juhn Song(Founder)Ho-Juhn Song, Ph.D(Co-Founder & Chief Executive Officer)
Co-investorsAtinum Investment Co. Ltd.DSC InvestmentKorea Investment PartnersSmilegate InvestmentSTIC InvestmentsSTIC Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.